Evotec

About:

Evotec is a pharmaceutical and life science company that provides drug discovery and gene therapy solutions.

Website: http://evotec.com

Twitter/X: evotec

Top Investors: European Investment Bank, Novo Holdings, Bill & Melinda Gates Foundation, Biotechnology Value Fund, Omega Funds

Description:

Evotec is a drug discovery alliance and development partnership rapidly progressing innovative product approaches with pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capitalists. Drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licencing of innovative drug candidates, and consulting arrangements.

Total Funding Amount:

$744M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Hamburg, Hamburg, Germany

Founded Date:

1993-01-01

Contact Email:

info(AT)evotec.com

Founders:

Charles Weissmann, Freimut Leidenberger, Heinrich M. Schulte, Karsten Henco, Manfred Eigen, Rudolf Rigler, Ulrich Aldag

Number of Employees:

5001-10000

Last Funding Date:

2023-12-19

IPO Status:

Public

© 2025 bioDAO.ai